[Federal Register Volume 60, Number 147 (Tuesday, August 1, 1995)]
[Notices]
[Page 39180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-18747]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 95N-0185]


Drug Export; Arimidex (Anastrozole) 1 Milligram (mg) Tablet

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of June 29, 1995 (60 FR 33810). 
The document announced that Zeneca Pharmaceuticals Inc., was requesting 
conditional approval for export of the human drug Arimidex 
(Anastrozole) 1 mg tablet to the United Kingdom. The document contained 
an error in indication for use. This document corrects that error.

 FOR FURTHER INFORMATION CONTACT: James E. Hamilton, Center for Drug 
Evaluation and Research (HFD-310), Food and Drug Administration, 7520 
Standish Pl., Rockville, MD 20855, 301-594-3150.

SUPPLEMENTARY INFORMATION: In FR Doc. 95-15969 appearing on page 33810 
in the Federal Register of Thursday, June 29, 1995, the following 
correction is made:
    On page 33810, in the second column, under the heading 
SUPPLEMENTARY INFORMATION, line 29, the word ``colorectal'' is 
corrected to read ``breast''.

    Dated: July 24, 1995.
Betty L. Jones,
Acting Deputy Director, Office of Compliance, Center for Drug 
Evaluation and Research.
[FR Doc. 95-18747 Filed 7-31-95; 8:45 am]
BILLING CODE 4160-01-F